Table 3.
The pooled results of Baduanjin exercise for plasma TG level in healthy participants or clinical patients.
| Participants | Numbers of comparisons | n/T | n/C | MD (95% CI) (mmol/L) |
P value | I 2 (%) | P heterogeneity |
|---|---|---|---|---|---|---|---|
| Baduanjin + routine treatment versus routine treatment | |||||||
| Clinical patients | 4 | 112 | 112 | −0.77 (−1.97, 0.42) | P = 0.2 | 94 | P < 0.00001 |
| Baduanjin versus no treatment | |||||||
| Clinical patients | 2 | 38 | 35 | −0.30 (−0.40, −0.19) | P < 0.00001 | 42 | P = 0.19 |
| Healthy participants | 4 | 66 | 70 | −0.22 (−0.31, −0.13) | P < 0.00001 | 0 | P = 0.88 |
| Baduanjin versus other exercises | |||||||
| Healthy participants | 2 | 49 | 47 | −0.21 (−0.51, 0.1) | P = 0.18 | 90 | P = 0.001 |
| Baduanjin + routine treatment versus other exercises + routine treatment | |||||||
| Clinical patients | 3 | 114 | 106 | 0.1 (−0.14, 0.35) | P = 0.41 | 0 | P = 0.9 |
T: The treatment group, C: The control group.